Clinical Study

The Use of Strontium-90 Beta Radiotherapy as Adjuvant Treatment for Conjunctival Melanoma

Table 1

Clinical data of participating patients.

PatientAgeGenderTumor locationTumor size (mm)Tumor thickness (mm) TNM
Classification1
Primary excision and cryotherapyMode of strontium treatmentTime to strontium treatment (months)Type of applicator

158FInferior temporal5 × 30.6T1N0MXYAdjuvant (base and lateral)3SIA 6
286FTemporal8 × 41T2N0MXYAdjuvant (base and lateral)2SIA 6
372MInferior temporal5 × 51T4N0MXYBase adjuvant 3SIA 6
471MInferior nasal10 × 76T1N0MXYAdjuvant (base and lateral)3SIA 6
592FTemporal6 × 42.5T2N0MXYAdjuvant (base and lateral)3SIA 6
672MTemporal0.7 × 0.3Not assessed thoroughly T4N0MXYSecondary to recurrence4SIA 6
763FTemporal6 × 40.6 mmT2N0MXYAdjuvant (base and lateral)2SIA 6
869MSuperior nasal3 × 1.81.9T1N0MXYAdjuvant (base and lateral)3SIA 6
961FTemporal2 × 24T1N0MXYAdjuvant (base and lateral)3SIA 6
1068FTemporal9 × 31 mmT2N0MXYSecondary to recurrence4SIA 6
1168MTemporal14 × 83T2N0MXYAdjuvant (base and lateral)1SIA 1
1276MInferior temporal11 × 4.56T2N0MXYAdjuvant (base and lateral)2SIA 6
1365FTemporal10 × 81.3T2N0MXYAdjuvant (base and lateral)3SIA 6
1460MNasal7 × 52T2N0MXYSecondary to recurrence3SIA 1
1569MTemporal13 × 61.5T2N0MXYAdjuvant (base and lateral)1SIA 1
1667MSuperonasal6 × 11T1N0MXYSecondary to recurrence1SIA 6
1763FTemporal7 × 2.51T2N0MXYAdjuvant (base and lateral)2SIA 6
1854FTemporal6 × 3 1T2N0MXYAdjuvant (base and lateral)1SIA 6
1969FSuperiorN/AN/AT1N0MXYAdjuvant (base and lateral)2SIA 6
2072MSuperior1.5 × 1.0Not assessed thoroughly T1N0MXYAdjuvant (base and lateral)4SIA 6

TNM classification primary tumour (T): TX: primary tumour cannot be assessed, T0: no evidence of primary tumour, T1: tumour of bulbar conjunctival occupying one quadrant or less, T2: tumour of the bulbar conjunctiva occupying more than 1 quadrant, T3: tumour of conjunctival fornix and palpebral conjunctiva or caruncle, T4: tumour invades eyelid, cornea, or orbit. Regional lymph nodes (N): N: NX: regional lymph nodes cannot be assessed, N0: no regional lymph node metastasis, N1: regional lymph node metastasis. Distant metastasis (M): MX: distant metastasis cannot be assessed, M0: no distant metastasis, M1: distant metastasis.
*SIA 6: 12 mm ophthalmic applicator, SIA 1: 18 mm ophthalmic applicator.